A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema

OBJECTIVE: To compare the safety and efficacy of different doses of intravitreal triamcinolone (ivTA) in treating clinically significant diabetic macular oedema (CSMO). METHODS: 63 eyes of 63 patients with CSMO and central foveal thickness (CFT) of ⩾250 μm on optical coherence tomography were random...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lam, Dennis S C, Chan, Carmen K M, Mohamed, Shaheeda, Lai, Timothy Y Y, Li, Kenneth K W, Li, Patrick S H, Tsang, Chi‐Wai, Chan, Wai‐Man, Shanmugam, Mahesh P
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2007
Assuntos:
Clinical Science - Extended Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1857621/
https://ncbi.nlm.nih.gov/pubmed/16973659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2006.102848
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados